516 related articles for article (PubMed ID: 31325071)
1. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy.
Rodin D; Sutradhar R; Nofech-Mozes S; Gu S; Faught N; Hahn E; Fong C; Trebinjac S; Paszat L; Rakovitch E
Breast Cancer Res Treat; 2022 Feb; 192(1):223-233. PubMed ID: 35083587
[TBL] [Abstract][Full Text] [Related]
3. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract][Full Text] [Related]
4. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
5. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
[TBL] [Abstract][Full Text] [Related]
6. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
[TBL] [Abstract][Full Text] [Related]
7. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
[TBL] [Abstract][Full Text] [Related]
8. The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.
Rakovitch E; Sutradhar R; Hallett M; Thompson AM; Gu S; Dumeaux V; Whelan TJ; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):221-230. PubMed ID: 31368035
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063
[TBL] [Abstract][Full Text] [Related]
10. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
11. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
[TBL] [Abstract][Full Text] [Related]
12. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
14. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
Rakovitch E; Gray R; Baehner FL; Sutradhar R; Crager M; Gu S; Nofech-Mozes S; Badve SS; Hanna W; Hughes LL; Wood WC; Davidson NE; Paszat L; Shak S; Sparano JA; Solin LJ
Breast Cancer Res Treat; 2018 Jun; 169(2):359-369. PubMed ID: 29388015
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
16. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
Mamtani A; Nakhlis F; Downs-Canner S; Zabor EC; Morrow M; King TA; Van Zee KJ
Ann Surg Oncol; 2019 Dec; 26(13):4264-4271. PubMed ID: 31440931
[TBL] [Abstract][Full Text] [Related]
17. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
[TBL] [Abstract][Full Text] [Related]
18. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS.
Paszat L; Sutradhar R; Zhou L; Nofech-Mozes S; Rakovitch E
Clin Breast Cancer; 2019 Feb; 19(1):35-46. PubMed ID: 30190195
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
20. Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.
Shurell E; Olcese C; Patil S; McCormick B; Van Zee KJ; Pilewskie ML
Cancer; 2018 Jan; 124(1):46-54. PubMed ID: 28960259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
